BRPI0517674A - sistema de cápsula mole de não-gelatina - Google Patents

sistema de cápsula mole de não-gelatina

Info

Publication number
BRPI0517674A
BRPI0517674A BRPI0517674-3A BRPI0517674A BRPI0517674A BR PI0517674 A BRPI0517674 A BR PI0517674A BR PI0517674 A BRPI0517674 A BR PI0517674A BR PI0517674 A BRPI0517674 A BR PI0517674A
Authority
BR
Brazil
Prior art keywords
gelatin
soft capsule
fillers
vehicle
active ingredients
Prior art date
Application number
BRPI0517674-3A
Other languages
English (en)
Inventor
Rickey S Shelley
Elizabeth Youngblood
Keith Tanner
Norman Stroud
Original Assignee
Scherer Technologies Inc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Inc R P filed Critical Scherer Technologies Inc R P
Publication of BRPI0517674A publication Critical patent/BRPI0517674A/pt
Publication of BRPI0517674B1 publication Critical patent/BRPI0517674B1/pt
Publication of BRPI0517674B8 publication Critical patent/BRPI0517674B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

SISTEMA DE CáPSULA MOLE DE NãO-GELATINA. A presente invenção refere-se a um sistema de encapsulação de não-gelatina para cápsulas moles preenchidas com líquidos, pela natureza do veículo, do equilíbrio catiõnico-iónico do veículo e dos ingredientes ativos, ou da concentração dos ingredientes e dos excipientes ativos que é difícil ou impossível encapsular comercialmente em cápsulas de gelatina. Em particular, o sistema é adaptado para a encapsulação de enchimentos altamente básicos ou alcalinos, O sistema proporciona uma concha com base predominantemente de amido e carragenina geleificante, que exibe alta resistência tanto aos enchimentos concentrados quanto aos enchimentos alcalinos, em particular, àqueles enchimentos que contêm sal ou sais de ácidos fracos e bases fortes.
BRPI0517674A 2004-11-08 2005-10-26 sistema de cápsula mole de não-gelatina contendo amido modificado e carragenina com solução de enchimento de natureza básica BRPI0517674B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/984,205 US8231896B2 (en) 2004-11-08 2004-11-08 Non-gelatin soft capsule system
US10/984,205 2004-11-08
PCT/US2005/038532 WO2006052452A1 (en) 2004-11-08 2005-10-26 Non-gelatin soft capsule system

Publications (3)

Publication Number Publication Date
BRPI0517674A true BRPI0517674A (pt) 2008-10-14
BRPI0517674B1 BRPI0517674B1 (pt) 2019-04-02
BRPI0517674B8 BRPI0517674B8 (pt) 2021-05-25

Family

ID=36316590

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0517674A BRPI0517674B8 (pt) 2004-11-08 2005-10-26 sistema de cápsula mole de não-gelatina contendo amido modificado e carragenina com solução de enchimento de natureza básica

Country Status (19)

Country Link
US (2) US8231896B2 (pt)
EP (2) EP2289496B1 (pt)
JP (1) JP5192816B2 (pt)
AR (1) AR051237A1 (pt)
AT (1) ATE536866T1 (pt)
AU (1) AU2005305232B2 (pt)
BR (1) BRPI0517674B8 (pt)
CA (1) CA2585721C (pt)
CY (1) CY1112518T1 (pt)
DK (1) DK1809261T3 (pt)
ES (2) ES2603225T3 (pt)
MX (1) MX2007005403A (pt)
PE (1) PE20061136A1 (pt)
PL (1) PL1809261T3 (pt)
PT (1) PT1809261E (pt)
SI (1) SI1809261T1 (pt)
TW (1) TWI405592B (pt)
UY (1) UY29200A1 (pt)
WO (1) WO2006052452A1 (pt)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2112920B1 (en) * 2003-06-26 2018-07-25 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US8394409B2 (en) * 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US20070053868A1 (en) * 2005-03-08 2007-03-08 Banner Pharmacaps, Inc. Solvent system for enhancing the solubility of pharmaceutical agents
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
CA2882048C (en) 2006-02-03 2020-03-24 Opko Renal, Llc Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
WO2007112581A1 (en) * 2006-04-03 2007-10-11 Isa Odidi Controlled release delivery device comprising an organosol coat
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
HUE037309T2 (hu) 2006-06-21 2018-08-28 Opko Ireland Global Holdings Ltd Terápia D-vitamin telítési szer alkalmazásával és D-vitamin hormon helyettesítõ szer
JP5021263B2 (ja) * 2006-10-02 2012-09-05 中日本カプセル 株式会社 皮膜用組成物
ES2401205T3 (es) 2007-04-25 2013-04-17 Cytochroma Inc. Composiciones de orales de liberación controlada que comprende un compuesto de vitamina D y un soporte céreo
WO2009047644A2 (en) 2007-04-25 2009-04-16 Cytochroma Inc. Method of treating vitamin d insufficiency and deficiency
CA2683514C (en) 2007-04-25 2019-07-09 Proventiv Therapeutics, Llc Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
US20090004231A1 (en) 2007-06-30 2009-01-01 Popp Shane M Pharmaceutical dosage forms fabricated with nanomaterials for quality monitoring
EP2229155A4 (en) * 2007-12-12 2010-12-29 Northern Innovations And Formulations Corp Particles in a capsule
GB0801643D0 (en) * 2008-01-29 2008-03-05 Probio Nutraceuticals As Product
KR101685031B1 (ko) 2008-04-02 2016-12-09 사이토크로마 인코포레이티드 비타민 d 결핍 및 관련 장애에 유용한 방법, 조성물, 용도 및 키트
KR101900505B1 (ko) 2009-09-10 2018-09-19 에프엠씨 코포레이션 고강도의 이음매 없는 알기네이트 캡슐
CN103037902A (zh) 2010-03-29 2013-04-10 赛特克罗公司 用于降低甲状旁腺水平的方法和组合物
MX344742B (es) * 2010-08-04 2017-01-05 Scherer Technologies Llc R P Composicion de formacion de pelicula para capsulas suaves.
KR101294614B1 (ko) 2012-03-16 2013-08-08 주식회사 서흥캅셀 타피오카 변성전분을 주기재로 사용한 연질 캡슐 피막 조성물
JP5597770B2 (ja) * 2011-04-20 2014-10-01 サフン カプセル カンパニー, リミテッド 崩解度及び被膜硬度を改善した非動物性軟質カプセル被膜組成物
KR101411364B1 (ko) * 2012-03-16 2014-06-30 주식회사 서흥 전분을 주기재로 사용한 연질 캡슐 피막 조성물
KR101178842B1 (ko) * 2011-04-20 2012-09-03 주식회사 서흥캅셀 붕해도 및 피막 경도를 개선한 비동물성 연질 캡슐 피막 조성물
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 d 방출 제형
WO2014152098A1 (en) 2013-03-15 2014-09-25 Banner Pharmacaps Inc. Non-gelatin enteric soft capsules
KR101445334B1 (ko) * 2013-06-05 2014-10-01 코스맥스바이오 주식회사 화학적 금속염을 포함하지 않는 식물성 연질캡슐조성물
JP5769760B2 (ja) * 2013-06-25 2015-08-26 アール.ピー. シェーラー テクノロジーズ エルエルシー ソフトカプセル用シェル形成組成物及びソフトカプセル
CN105358138A (zh) * 2013-07-03 2016-02-24 R.P.谢勒技术有限公司 包含非索非那定的胶囊制剂
WO2015059864A1 (ja) * 2013-10-25 2015-04-30 コニカミノルタ株式会社 粒子状肥料およびその製造方法
CN103550065B (zh) * 2013-10-26 2015-01-28 中山市凯博思淀粉材料科技有限公司 一种复合挤出法生产淀粉基软胶囊的方法
CN103495176B (zh) * 2013-10-26 2015-01-28 中山市凯博思淀粉材料科技有限公司 一种共混挤出法制备淀粉基软胶囊的方法
CN103520133B (zh) * 2013-10-26 2015-02-04 中山市凯博思淀粉材料科技有限公司 一种淀粉基软胶囊的制备方法
CN103893771B (zh) * 2014-04-21 2015-08-26 湖南尔康制药股份有限公司 一种用于生产淀粉材料软胶囊的成膜组合物及其制备方法
CA2910865C (en) 2014-07-15 2016-11-29 Isa Odidi Compositions and methods for reducing overdose
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
CN104337793A (zh) * 2014-10-16 2015-02-11 浙江春宝胶囊有限公司 一种非明胶软胶囊壳的配方
AU2016361585A1 (en) * 2015-11-23 2018-07-12 Undoo, LLC Composition of olivetol and method of use reduce or inhibit the effects of tetrahydrocannabinol in the human body
JP6926453B2 (ja) * 2015-12-03 2021-08-25 大正製薬株式会社 カプセル組成物
EP4596045A3 (en) 2016-03-28 2025-10-15 EirGen Pharma Ltd. Methods of vitamin d treatment
MX2018014407A (es) * 2016-05-25 2019-02-21 Tsi Group Ltd Estabilizacion de formulaciones de acido beta-hidroxiisovalerico en capsulas de gel blando.
CN110494415A (zh) 2017-03-03 2019-11-22 睿治尼斯公司 具有改善的稳定性的制剂
US10711119B2 (en) 2018-01-10 2020-07-14 Cp Kelco Aps Carrageenan-based compositions for films and capsules
US20220280436A1 (en) * 2019-07-23 2022-09-08 R.P. Scherer Technologies, Llc Softshell capsule formulations, and methods of preparation and use thereof
AU2022249084A1 (en) * 2021-04-01 2023-11-09 R.P. Scherer Technologies, Llc Phospholipids as anion chelating agents in pharmaceutical formulations
CA3224069A1 (en) * 2021-07-06 2023-01-12 Karunakar Sukuru Softgel capsule
AU2021107198A4 (en) * 2021-08-24 2021-12-09 Blackmores Ltd A softgel capsule composition, and a process for producing a softgel capsule therefrom
EP4176724A1 (en) 2021-11-09 2023-05-10 Universität Hohenheim Use of an oleogel as a layer or coating
CA3263875A1 (en) * 2022-08-12 2024-02-15 R.P. Scherer Technologies, Llc FAST-DISSOLVING SOFT-COATED CAPSULES
AU2024329567A1 (en) * 2023-08-18 2026-03-12 R.P. Scherer Technologies, Llc Softgel capsule including a non-steroidal anti-inflammatory drug and acetaminophen
WO2025064293A1 (en) * 2023-09-18 2025-03-27 R.P. Scherer Technologies, Llc Fast dissolving softgel capsules including ibuprofen

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2118040A (en) 1982-02-15 1983-10-26 Hoechst Uk Ltd Oral anti-diabetic preparation
GB8305693D0 (en) * 1983-03-02 1983-04-07 Scherer Ltd R P Pharmaceutical compositions
DE3307353C2 (de) * 1983-03-02 1985-01-31 R.P. Scherer GmbH, 6930 Eberbach Polyethylenglykolhaltige Weichgelatinekapsel und Verfahren zu ihrer Herstellung
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
JPS63164858A (ja) * 1986-12-27 1988-07-08 Unie Koroido Kk 軟カプセルの外皮
JPH0525037A (ja) 1991-07-01 1993-02-02 Upjohn Co:The 経口投与酵素感受性腸溶製剤
GB9226238D0 (en) * 1992-12-16 1993-02-10 Scherer Ltd R P Encapsulation apparatus and process
US5376688A (en) * 1992-12-18 1994-12-27 R. P. Scherer Corporation Enhanced solubility pharmaceutical solutions
US5505961A (en) * 1993-08-05 1996-04-09 R. P. Scherer Corporation Gelatin capsules containing a highly concentrated acetaminophen solution
GB9705770D0 (en) 1997-03-20 1997-05-07 Scherer Corp R P Gelatin encapsulation techniques
US20030104048A1 (en) * 1999-02-26 2003-06-05 Lipocine, Inc. Pharmaceutical dosage forms for highly hydrophilic materials
US6340473B1 (en) * 1999-07-07 2002-01-22 R.P. Scherer Technologies, Inc. Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
US6387400B1 (en) 2000-08-29 2002-05-14 R.P. Scherer Technologies, Inc. Process for preparing pharmaceutical compositions for use with soft gelatin formulations
US6884060B2 (en) * 2001-11-02 2005-04-26 R.P. Scherer Technologies, Inc. Apparatus for manufacturing encapsulated products
US7887838B2 (en) 2002-01-18 2011-02-15 Banner Pharmacaps, Inc. Non-gelatin film and method and apparatus for producing same
EP1545477A4 (en) * 2002-09-13 2006-11-22 Cydex Inc CAPSULES CONTAINING AQUEOUS FILLING COMPOSITIONS STABILIZED WITH DERIVED CYCLODEXTRIN
JP2004250369A (ja) * 2003-02-19 2004-09-09 Fuji Capsule Kk 軟カプセル剤皮膜組成物
US20050137262A1 (en) 2003-12-22 2005-06-23 Hu Patrick C. Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses

Also Published As

Publication number Publication date
EP2289496A2 (en) 2011-03-02
BRPI0517674B8 (pt) 2021-05-25
JP2008519075A (ja) 2008-06-05
HK1108363A1 (en) 2008-05-09
MX2007005403A (es) 2007-05-16
US8377470B2 (en) 2013-02-19
EP1809261A1 (en) 2007-07-25
EP2289496A3 (en) 2011-03-09
US20060099246A1 (en) 2006-05-11
TW200630122A (en) 2006-09-01
ES2379970T3 (es) 2012-05-07
CA2585721C (en) 2014-07-15
AR051237A1 (es) 2006-12-27
SI1809261T1 (sl) 2013-09-30
PT1809261E (pt) 2012-04-11
BRPI0517674B1 (pt) 2019-04-02
WO2006052452A1 (en) 2006-05-18
AU2005305232B2 (en) 2010-03-25
EP1809261B1 (en) 2011-12-14
DK1809261T3 (da) 2012-04-02
PE20061136A1 (es) 2006-10-27
EP1809261A4 (en) 2008-09-10
TWI405592B (zh) 2013-08-21
CY1112518T1 (el) 2015-12-09
US8231896B2 (en) 2012-07-31
AU2005305232A1 (en) 2006-05-18
PL1809261T3 (pl) 2012-06-29
EP2289496B1 (en) 2016-08-17
CA2585721A1 (en) 2006-05-18
JP5192816B2 (ja) 2013-05-08
ATE536866T1 (de) 2011-12-15
US20120269889A1 (en) 2012-10-25
ES2603225T3 (es) 2017-02-24
UY29200A1 (es) 2006-06-30

Similar Documents

Publication Publication Date Title
BRPI0517674B8 (pt) sistema de cápsula mole de não-gelatina contendo amido modificado e carragenina com solução de enchimento de natureza básica
Depfenhart et al. Potential new treatment strategies for COVID-19: is there a role for bromhexine as add-on therapy?
Ketter et al. Virus impact on lipids and membranes
Kumar et al. Host immune response and immunobiology of human SARS-CoV-2 infection
Lefkimmiatis et al. The inner and outer compartments of mitochondria are sites of distinct cAMP/PKA signaling dynamics
BRPI0512000A (pt) cápsula estável contra mastigação
JP2010529999A5 (pt)
BR0308188A (pt) Forma de administração a ser aplicada oralmente, para substâncias ativas básicas de difìcil solubilidade
BRPI0418330A (pt) composições sólidas de drogas de solubilidade baixa e poloxámeros
ES2184408T3 (es) Sistema transdermico que contiene un antioxidante.
BR0013826A (pt) Formas orais de apresentação
BR0214155A (pt) Almofada protetora para seios contendo um ingrediente que proporciona benefìcios para a pele
BR9908815A (pt) Dispositivo de inalação
CY1115195T1 (el) Νεες φαρμακευτικες τυποποιησεις εναντι της μη προβλεπομενης χρησης των φαρμακων
BR112014015162A2 (pt) sistema de detecção para detectar objetos magnéticos no organismo humano
BRPI0414864A (pt) composição farmacêutica multiparticulada compreendendo ácido micofenólico ou micofenolato de sódio e combinação com rapamicida
CO6321129A2 (es) Inhibidor de la cristalizacion y su uso en capsulas de gelatina
EA200601908A1 (ru) Контроль прорывных кровотечений при пролонгированном режиме приёма гормональных контрацептивов
BR0308316A (pt) Sais de nateglinida
Parthasarathy et al. Defeating the trypanosomatid trio: proteomics of the protozoan parasites causing neglected tropical diseases
BRPI0620229A8 (pt) formulação
WO2005046727A3 (en) Ibuprofen-containing soft gelatin capsules
BR9611455A (pt) Compostos e métodos para a detecção e prevenção de infecção por t. cruzi.
BR0307056A (pt) Composição farmacêutica orodispersìvel de ivabradina
BR0009265A (pt) Derivados com base em esfingóide e usos destes

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/04/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/04/2019, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 26/10/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF